CONTEXT: Circulating tumor DNA (ctDNA) is a promising biomarker in cancer. MATERIALS AND METHODS: We generated xenograft models of cancer and detected ctDNA in plasma by qRCR targeting human AluJ sequences. RESULTS: Our assay reached single cell sensitivity in vitro and a correlation between ctDNA amount and tumor size was observed in vivo. Treatment with a mitogen activated protein kinase kinase (MEK)-inhibitor (BAY 869766) reduced ctDNA levels. Using this assay, we also confirmed that high levels of cell-free DNA are found in cancer patients compared to healthy individuals. DISCUSSION AND CONCLUSION: We show that ctDNA may be useful biomarker for monitoring tumor growth and treatment response.
CONTEXT: Circulating tumor DNA (ctDNA) is a promising biomarker in cancer. MATERIALS AND METHODS: We generated xenograft models of cancer and detected ctDNA in plasma by qRCR targeting human AluJ sequences. RESULTS: Our assay reached single cell sensitivity in vitro and a correlation between ctDNA amount and tumor size was observed in vivo. Treatment with a mitogen activated protein kinase kinase (MEK)-inhibitor (BAY 869766) reduced ctDNA levels. Using this assay, we also confirmed that high levels of cell-free DNA are found in cancerpatients compared to healthy individuals. DISCUSSION AND CONCLUSION: We show that ctDNA may be useful biomarker for monitoring tumor growth and treatment response.
Authors: Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld Journal: Nat Rev Cancer Date: 2017-02-24 Impact factor: 60.716
Authors: Györgyi Műzes; Ferenc Sipos; István Fűri; Miklós Constantinovits; Sándor Spisák; Barnabás Wichmann; Gábor Valcz; Zsolt Tulassay; Béla Molnár Journal: Dig Dis Sci Date: 2014-09-13 Impact factor: 3.199
Authors: Ferenc Sipos; Györgyi Műzes; István Fűri; Sándor Spisák; Barnabás Wichmann; Tiana M Germann; Miklós Constantinovits; Tibor Krenács; Zsolt Tulassay; Béla Molnár Journal: Pathol Oncol Res Date: 2014-04-11 Impact factor: 3.201
Authors: Dolores C García-Olmo; María G Picazo; Inmaculada Toboso; Ana I Asensio; Damián García-Olmo Journal: Mol Cancer Date: 2013-02-04 Impact factor: 27.401
Authors: Svetlana V Kostyuk; Marina S Konkova; Elizaveta S Ershova; Anna J Alekseeva; Tatiana D Smirnova; Sergey V Stukalov; Ekaterina A Kozhina; Nadezda V Shilova; Tatiana V Zolotukhina; Zhanna G Markova; Vera L Izhevskaya; Ancha Baranova; Natalia N Veiko Journal: PLoS One Date: 2013-10-17 Impact factor: 3.240
Authors: Alberto Ramírez; Houria Boulaiz; Cynthia Morata-Tarifa; Macarena Perán; Gema Jiménez; Manuel Picon-Ruiz; Ahmad Agil; Olga Cruz-López; Ana Conejo-García; Joaquín M Campos; Ana Sánchez; María A García; Juan A Marchal Journal: Oncotarget Date: 2014-06-15